DNA-Encoded Library Screening for Small Molecule Drug Discovery

DEL Process

The construction of DEL involves several sequential steps:

1. Synthesize the leading DNA: The project starts by creating a double-stranded DNA molecule that features both sticky ends and a hairpin structure for coding purposes.
2. Gradually introduce small chemical molecules: The introduction of a small chemical molecule triggers its attachment to the DNA chain via chemical reaction and the corresponding DNA sequence becomes part of the coding region.
3. Generate a compound library: Combinatorial chemistry merges multiple small chemical molecules to form an extensive compound library where each compound carries a unique DNA identifier.

The screening process includes the following steps:

1. Affinity screening: The target protein is co-incubated with the constructed DEL before the unbound compounds are washed away to isolate those bound to the target protein.
2. PCR amplification: The bound compound DNA sequence undergoes amplification through PCR technology.
3. Sequencing and decoding: The DNA sequence undergoes high-throughput sequencing and scientists decode the compound structure by applying coding rules.

The advantages of DEL technology:

• High-throughput screening: Multiple compounds can be tested together in one reaction system which greatly enhances screening efficiency.
• Low cost: Traditional compound storage and screening requirements for hardware become unnecessary through this technology.
• Flexibility: The design of screening strategies varies depending on the specific targets they aim to address.

The DEL approach plays a pivotal role in drug discovery through extensive use in modern drug research and development programs.

DEL Advantages and Limitations During the Drug Development Process

The application of DNA-encoded library screening technology (DEL) presents both major benefits and drawbacks for new drug development.

Figure 1. On-cell DEL-based small-molecule discovery. (Sources: Peterson AA, et al. 2023)

Advantages of DNA-encoded library screening technology:

1. High-throughput screening: DEL technology allows researchers to examine hundreds of millions of compounds simultaneously which accelerates the screening process while reducing costs and boosting efficiency.
2. Extensive target coverage: DNA-encoded library screening technology enables researchers to analyze targets that conventional methods struggle to identify such as protein-protein interaction targets.
3. Chemical diversity: DEL technology enables the production of numerous compounds that display high chemical variety throughout expansive chemical space.
4. Cost-effectiveness: DEL technology offers significant improvements over traditional high-throughput screening methods concerning both synthesis time and cost.
5. Affinity screening: DEL technology employs affinity screening to identify high-affinity compounds through high-throughput sequencing and then re-synthesizes these lead compounds for optimization.

Limitations of DNA-encoded library screening technology:

1. Synthesis method limitations: DEL technology demands specific synthesis reaction conditions for its DNA-encoded tags. The construction of compound libraries faces restrictions because numerous organic chemical reaction conditions prove incompatible with DNA.
2. Target expression and stability: The screening of targets which are hard to express or purify and those involving live cell systems presents difficulties and certain biological targets have the potential to damage DNA molecules during the process.
3. Data processing and accuracy: DEL technology produces vast amounts of data which needs proper processing tools and noise interference that reduces the accuracy of screening results.
4. Technical complexity and uncertainty: As the number of molecular species expands DEL technology becomes more complex and uncertain which can result in decreased screening quality higher costs and reduced technical benefits.
5. Limited application scenarios: DEL technology currently faces constraints including challenges with screening targets that cannot be easily expressed or purified and live cell systems.

The DNA-encoded library screening technology offers meaningful benefits for new drug research and development yet encounters both technical and practical obstacles. The ongoing advancements and improvements in technology will progressively resolve these limitations.

Recent Advancements in DNA-encoded Library Screening Technology

The most recent advancements in DNA-encoded library screening technology within biomedical research are described below:

1. Application progress of DEL technology:

• Protein-protein interaction inhibitors: DEL technology succeeded in discovering protein-protein interaction blockers through RIP1 kinase inhibitor identification and optimization.
• Transmembrane protein inhibitors: DEL technology enabled successful transmembrane protein inhibitor screening which led to discovering soluble epoxide hydratase inhibitors for chronic obstructive pulmonary disease.
• PROTAC molecules: The DEL technology proves to be highly effective in creating and testing PROTAC ternary complexes. DEL technology enabled the Chengdu Pioneer Research Team to refine the design and screening process of PROTAC ternary complexes.

2. Optimization and innovation of DEL technology:

• Affinity screening method: The affinity screening method of DEL technology undergoes continuous optimization through various methods such as affinity screening for solidified target proteins with compound libraries and affinity screening of non-solidified target proteins with compound libraries.
• Cell-based screening: The first cell-based DEL screening work was documented by GlaxoSmithKline and Cai et al. Cai et al. performed DEL screening of cytosolic and surface protein targets.
• High-throughput sequencing and data analysis: The decoding and analysis of data post DEL screening depend on high-throughput sequencing technology while lead compounds emerge from frequency comparisons of DNA codes before and after screening.

Conclusion

DNA-encoded library screening technology's use in biomedicine keeps expanding with a particular emphasis on new drug discovery and optimization processes. DEL technology will likely achieve new breakthroughs in multiple fields through continued technical optimization and innovative developments.